Unlocking The Potential of YBX2: A Protein Target for Drug Development

Target Name: YBX2

NCBI ID: G51087

YBX2

Unlocking The Potential of YBX2: A Protein Target for Drug Development

YBX2 (Contri) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of YBX2 is its role in cell proliferation. YBX2 has been shown to play a negative role in cell proliferation, by inhibiting the activity of the protein kinase inhibitor p21 (p21), which promotes cell growth and division.

In addition to its role in cell proliferation, YBX2 is also involved in the regulation of cell death. Studies have shown that YBX2 has been shown to play a positive role in the regulation of cell death, by promoting the formation of apoptosis (programmed cell death ) in response to various stressors, such as exposure to chemotherapy drugs or radiation.

YBX2 has also been shown to play a role in the regulation of cellular immigration. Studies have shown that YBX2 promotes the migration of cells to new environments, such as the brain, and is involved in the development of new tissues and organs.

In addition to its role in cell proliferation and migration, YBX2 is also involved in the regulation of inflammation. Studies have shown that YBX2 has been shown to play a negative role in the regulation of inflammation, by inhibiting the production of pro-inflammatory cytokines.

Despite its many important functions, YBX2 is still poorly understood, and much more research is needed to fully understand its role in various diseases. One potential avenue for research is the use of YBX2 as a drug target. By inhibiting the activity of YBX2, researchers may be able to develop new treatments for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, YBX2 (Contri) is a protein that is involved in a number of important functions in the regulation of cell growth, proliferation, and death. Its role in these processes makes it an attractive target for drug development, and further research is needed to fully understand its functions and potential as a drug.

Protein Name: Y-box Binding Protein 2

Functions: Major constituent of messenger ribonucleoprotein particles (mRNPs). Involved in the regulation of the stability and/or translation of germ cell mRNAs. Binds to Y-box consensus promoter element. Binds to full-length mRNA with high affinity in a sequence-independent manner. Binds to short RNA sequences containing the consensus site 5'-UCCAUCA-3' with low affinity and limited sequence specificity. Its binding with maternal mRNAs is necessary for its cytoplasmic retention. May mark specific mRNAs (those transcribed from Y-box promoters) in the nucleus for cytoplasmic storage, thereby linking transcription and mRNA storage/translational delay (By similarity)

The "YBX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about YBX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets